ARCHIVES

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

This article is from The Cancer Letter archive.

Vol. 35 No. 15 | April 17, 2009

Download PDF Visit The Full Archive

Related Articles

Clinical Trials: NCI Puts State of Science Meetings on the Web

May 12, 2000

Bepler To Lead Karmanos Cancer Institute

January 29, 2010

Cancer Meetings Listed

November 1, 1996

Only 20 Percent Of At-Risk Patients Are Screened For HBV Before Therapy

November 25, 2011

Program Announcements Non-Invasive Detection Of Lung Cancer

April 15, 1983

BCF Members Miffed When NCI Refuses To Delay New Breast Cancer RFA To Allow Them Chance To Study It

April 8, 1983